Oncology Central

Artificial intelligence to predict cancer immunotherapy response

Researchers have utilized artificial intelligence to establish a radiomic signature, which could predict the effectiveness of cancer immunotherapy. The findings were recently published in The Lancet Oncology.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.